Skip to main content
. 2021 May 4;2(5):293–300. doi: 10.1302/2633-1462.25.BJO-2021-0006

Table III.

Complications.

Variable Total (%) ≤ 65 > 65 p-value < 70 ≥ 70 p-value
n 1,004 430 574 597 407
NJR notifiable
Revision, n (%)
DAIR 7 (0.7) 1 6 4 3
Revision for dislocation 3 (0.3) 1 2 2 1
Traumatic periprosthetic fracture 3 (0.3) 3 1 2
Total 13 (1.3) 2 (0.5) 11 (1.9) 0.382 7 (1.2) 6(1.5) 0.871
Re-revision, n (%)
Aseptic loosening femoral component (previous DAIR) 1 (0.1) 1 1
Death within 90 days, n (%) 3 (0.3) 1 (0.2) 2 (0.3) 1 (0.2) 2 (0.5)
Non NJR notifiable
Intraoperative*, n (%)
Calcar crack and cable 10 (1.0) 4 6 6 4
GT fracture and cable 1 (0.1) 1 1
Postoperative, n (%)
Transient fem nerve palsy 1 (0.1) 1 1
Community cardiac arrest 1 (0.1) 1 1
Dislocation × 1 6 (0.6) 2 4 (1 open reduction) 4 2 (1 open reduction)
Dislocation × 2 1 (0.1) 1 1
Dislocation × 3 1 (0.1) 1 1
Irreducible dislocation 1 (0.1) 1 1
(All dislocation including revision) 12 (1.2) 3 9 0.892 6 6 0.968
Traumatic PP fracture (conservative) 5 (0.5) 1 4 2 3
ORIF B1 fracture 2 (0.2) 2 2
(All postop fractures including revision) 10 (1.0) 1 9 0.801 3 7 0.856
(All operative fractures, B1 and B2) 5 (0.5) 5 1 4
Postop myocardial infarction 1 (0.1) 1 1
Postop pulmonary embolus 1 (0.1) 1 1
Aseptic loosening femoral component (surveillance) 1 (0.1) 1 1
Total non-notifiable 32 (3.2) 9 23 0.204 14 18 0.861
All complications 48 (4.8) 12/430 36/574 0.802 23/597 25/407 0.856
*

MDS recorded but not published.

DAIR, debridement, antibiotics, and implant retention; GT, greater trochanter; NJR, National Joint Registry; ORIF, open reduction, internal fixation.; PP, periprosthetic